Department of Pediatrics, University of California San Diego School of Medicine, 9500 Gilman Drive 0741, La Jolla, California 92093, USA.
Nat Rev Microbiol. 2013 Dec;11(12):849-62. doi: 10.1038/nrmicro3138. Epub 2013 Nov 11.
Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task. Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure. To develop these next-generation medicines, public-private partnerships are funding innovative approaches to identify compounds that target multiple parasite species at multiple stages of the parasite life cycle. In this Review, we discuss the cell-, chemistry- and target-based approaches used to discover new drug candidates that are currently in clinical trials or undergoing preclinical testing.
消除疟疾最近被重新提上全球卫生重点议程,但当前的治疗方法似乎还远远不够。消除疟疾需要新型药物,既能缓解症状,又能预防传播,并提供根治方法。为了开发这些新一代药物,公私合作伙伴关系正在为创新方法提供资金,以寻找针对寄生虫生命周期多个阶段的多种寄生虫物种的化合物。在这篇综述中,我们讨论了用于发现目前处于临床试验或临床前测试阶段的新药候选物的基于细胞、化学和靶标的方法。